2Komorowski J, Jankiewicz-Wika J, Siejka A. Monoclonal anti- TNFalpha antibody (infliximab) in the treatment of patient with thyroid associated ophthalmopathy[J]. Klin Oczna,2007, 109(10/12) :457-460. 被引量：1
3Kung AW,Yau CC,Cheng AC. The action of methimazole and L-thyroxine in radioiodine therapy: a prospective study on the incidence of hypothyroidism[J]. Thyroid, 1995,5 (1) : 7-12. 被引量：1
4Bartalena L,Pinchera A, Marcocci C. Management of Graves' ophthalmopathy: reality and perspectives [J]. Endocr Rev,2000,21(2):168-199. 被引量：1
1Given-Wilson R,Pope RM,Michell MJ,et al.The use of real-time orbital ultrasound in Graves' ophthalmopathy:a comparison with computed tomography.Br J Radiol,1989,62:705～709. 被引量：1
2Wiersinga WM,Prummel MF.An evidence-based approach to the treatment of Graves'ophthalmopathy.Edocrinol Metab Clin North Am,2000,29:297～319. 被引量：1
5PrummelMF,MouritsMP,BerghoutA ,etal.PrednisoneandcyclosporineinthetreatmentofsevereGraves′ophthalmopathy[].The New England Journal of Medicine.1989 被引量：1
10Zatz R,Noronha IL,Fujihara CK.Experimental and clinical rationale for use of MMF in nontransplant progressive nephropathies[].American Journal of Physiology Renal Physiology.2002 被引量：1
